Most Recent

image: Infographic: Immune Irritation in the Gut

Infographic: Immune Irritation in the Gut

By | June 1, 2017

A look at how gluten affects patients with celiac disease

0 Comments

image: Infographic: Proteasome Basics

Infographic: Proteasome Basics

By | May 1, 2017

The structure and function of the cell's protein-degrading machine

0 Comments

image: Infographic: The Cost of Drug Development

Infographic: The Cost of Drug Development

By | February 1, 2017

Expensive clinical trials and few drug approvals can drive up drug prices for consumers.

0 Comments

image: Infographic: Repurposing Strategies

Infographic: Repurposing Strategies

By | January 1, 2017

Novel uses for existing and failed drugs may save companies time and money in bringing new therapeutics to market.

0 Comments

image: A Complex Disorder

A Complex Disorder

By , , and | November 1, 2015

Factors that likely contribute to obesity include disruptions to intercellular signaling, increased inflammation, and changes to the gut microbiome.  

0 Comments

image: Not Immune to Fat

Not Immune to Fat

By | November 1, 2015

The effect of a high-fat diet on murine T cells

0 Comments

image: Ubiquitin Chains in Action

Ubiquitin Chains in Action

By | July 1, 2012

Present in every tissue of the body, ubiquitin appears to be involved in a dizzying array of functions, from cell cycle and division to organelle and ribosome biogenesis, as well as the response to viral infection. The protein plays at least two role

0 Comments

image: Ubiquitin basics

Ubiquitin basics

By | July 1, 2012

Despite its discovery as a protein that seems to show up everywhere, at least in eukaryotic cells, researchers are only beginning to scratch the surface of all of the cellular functions involving ubiquitin. 

0 Comments

image: Delivering New Genes

Delivering New Genes

By | June 1, 2012

Gene therapies typically involve the introduction of genetic material into target cells to replace or supplement an existing, usually dysfunctional, gene. 

0 Comments

image: Designing Transition-State Inhibitors

Designing Transition-State Inhibitors

By | May 1, 2012

A transition-state mimic has the power to bind an enzyme at its tipping point as strongly as any available inhibitor and more strongly than most, preventing enzymatic activity. 

0 Comments

Popular Now

  1. So You’ve Been Mistaken as a White Nationalist
  2. Opinion: We Need a Replacement for Beall’s List
  3. Trump Releases Science Spending Priorities for FY2019
  4. Seeding the Gut Microbiome Prevents Sepsis in Infants
AAAS